Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?

Programmed death 1 (PD-1, CD279) and programmed death ligand 1 (PD-L1, CD274) are involved in generating tumor-associated immunosuppression by suppression of T-cell proliferation and interleukin 2 (IL-2) production and immune checkpoint inhibitors targeting these molecules are showing compelling act...

Descripción completa

Detalles Bibliográficos
Autores principales: Preusser, Matthias, Berghoff, Anna S., Wick, Wolfgang, Weller, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766797/
https://www.ncbi.nlm.nih.gov/pubmed/26501438
http://dx.doi.org/10.5414/NP300922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766797/
https://www.ncbi.nlm.nih.gov/pubmed/26501438
http://dx.doi.org/10.5414/NP300922

Ejemplares similares